diabetes

You have accessRestricted Access
Effect of Apabetalone on Cardiovascular Events in Diabetes, CKD, and Recent Acute Coronary Syndrome
Kamyar Kalantar-Zadeh, Gregory G. Schwartz, Stephen J. Nicholls, Kevin A. Buhr, Henry N. Ginsberg, Jan O. Johansson, Ewelina Kulikowski, Kenneth Lebioda, Peter P. Toth, Norman Wong, Michael Sweeney, Kausik K. Ray and on behalf of the BETonMACE Investigators

CJASN May 2021, 16 (5) 705-716; DOI: https://doi.org/10.2215/CJN.16751020

Add to Selected Citations
You have accessRestricted Access
SGLT2 Inhibitors in Diabetic Kidney Disease
Sophia Zoungas and Ian H. de Boer

CJASN April 2021, 16 (4) 631-633; DOI: https://doi.org/10.2215/CJN.18881220

Add to Selected Citations
Open Access
The Patient Voice in Health Care Decision Making
Tami Sadusky and Clint Hurst

CJASN March 2021, CJN.18191120; DOI: https://doi.org/10.2215/CJN.18191120

Add to Selected Citations
You have accessRestricted Access
Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria
Meg Jardine, Zien Zhou, Hiddo J. Lambers Heerspink, Carinna Hockham, Qiang Li, Rajiv Agarwal, George L. Bakris, Christopher P. Cannon, David M. Charytan, Tom Greene, Adeera Levin, Jing-Wei Li, Brendon L. Neuen, Bruce Neal, Richard Oh, Megumi Oshima, Carol Pollock, David C. Wheeler, Dick de Zeeuw, Hong Zhang, Bernard Zinman, Kenneth W. Mahaffey and Vlado Perkovic

CJASN March 2021, 16 (3) 384-395; DOI: https://doi.org/10.2215/CJN.15260920

Add to Selected Citations
You have accessRestricted Access
Sex Disparity in Deceased-Donor Kidney Transplant Access by Cause of Kidney Disease
Patrick Ahearn, Kirsten L. Johansen, Jane C. Tan, Charles E. McCulloch, Barbara A. Grimes and Elaine Ku

CJASN February 2021, 16 (2) 241-250; DOI: https://doi.org/10.2215/CJN.09140620

Add to Selected Citations
Open Access
Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19
Benjamin Bowe, Miao Cai, Yan Xie, Andrew K. Gibson, Geetha Maddukuri and Ziyad Al-Aly

CJASN January 2021, 16 (1) 14-25; DOI: https://doi.org/10.2215/CJN.09610620

Add to Selected Citations
Open Access
Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease
John P. Hanrahan, Ian H. de Boer, George L. Bakris, Phebe J. Wilson, James D. Wakefield, Jelena P. Seferovic, Jennifer G. Chickering, Yueh-tyng Chien, Kenneth Carlson, Michael D. Cressman, Mark G. Currie, G. Todd Milne and Albert T. Profy

CJASN January 2021, 16 (1) 59-69; DOI: https://doi.org/10.2215/CJN.08410520

Add to Selected Citations
You have accessRestricted Access
Forever Starts Now
Sradha Kotwal and Vlado Perkovic

CJASN January 2021, 16 (1) 6-8; DOI: https://doi.org/10.2215/CJN.18141120

Add to Selected Citations
You have accessRestricted Access
Network Meta-Analysis of Novel Glucose-Lowering Drugs on Risk of Acute Kidney Injury
Min Zhao, Shusen Sun, Zhenguang Huang, Tiansheng Wang and Huilin Tang

CJASN January 2021, 16 (1) 70-78; DOI: https://doi.org/10.2215/CJN.11220720

Add to Selected Citations
You have accessRestricted Access
Mineralocorticoid Receptor Antagonists for Diabetic Kidney Disease
Peter Rossing

CJASN December 2020, 15 (12) 1696-1698; DOI: https://doi.org/10.2215/CJN.16201020

Add to Selected Citations

Main menu

User menu

Search

diabetes

Pages

Articles

Information for Authors

About

Journal Information

More Information